1 February 2023 false No description of principal activity Taxfiler 2024.5 13875135business:PrivateLimitedCompanyLtd2023-02-012024-01-31 138751352023-01-31 138751352023-02-012024-01-31 13875135business:AuditExemptWithAccountantsReport2023-02-012024-01-31 13875135business:FilletedAccounts2023-02-012024-01-31 138751352024-01-31 13875135business:Director12023-02-012024-01-31 13875135business:RegisteredOffice2023-02-012024-01-31 138751352023-01-31 13875135core:WithinOneYear2024-01-31 13875135core:WithinOneYear2023-01-31 13875135core:ShareCapitalcore:PreviouslyStatedAmount2024-01-31 13875135core:ShareCapitalcore:PreviouslyStatedAmount2023-01-31 13875135core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-01-31 13875135core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-01-31 13875135core:PreviouslyStatedAmount2024-01-31 13875135core:PreviouslyStatedAmount2023-01-31 13875135business:SmallEntities2023-02-012024-01-31 13875135countries:EnglandWales2023-02-012024-01-31 138751352022-02-012023-01-31 iso4217:GBP xbrli:pure
Company Registration No. 13875135 (England and Wales)
ALIA BIOTECH LTD Unaudited accounts for the year ended 31 January 2024
ALIA BIOTECH LTD Unaudited accounts Contents
Page
- 2 -
ALIA BIOTECH LTD Company Information for the year ended 31 January 2024
Director
Gholamhossein LIAGHAT
Company Number
13875135 (England and Wales)
Registered Office
226 Upper Richmond Road West London London SW14 8AH England
Accountants
Fouladi and Co Accountants 30 High Street Cradley Heath West Midlands B64 5HL
- 3 -
ALIA BIOTECH LTD Accountants' report
Accountants' report to the director of ALIA BIOTECH LTD on the preparation of the unaudited statutory accounts for the year ended 31 January 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of ALIA BIOTECH LTD for the year ended 31 January 2024 as set out on pages 5 - 6 from the company's accounting records and from information and explanations you have given us.
This report is made solely to the Board of Directors of ALIA BIOTECH LTD, as a body, in accordance with the terms of our engagement letter dated 5 September 2024. Our work has been undertaken solely to prepare for your approval the accounts of ALIA BIOTECH LTD and state those matters that we have agreed to state to them, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than ALIA BIOTECH LTD and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that ALIA BIOTECH LTD has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of ALIA BIOTECH LTD. You consider that ALIA BIOTECH LTD is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of ALIA BIOTECH LTD. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
Fouladi and Co Accountants 30 High Street Cradley Heath West Midlands B64 5HL 5 September 2024
- 4 -
ALIA BIOTECH LTD Statement of financial position as at 31 January 2024
2024 
2023 
Notes
£ 
£ 
Current assets
Cash at bank and in hand
12,723 
100 
Creditors: amounts falling due within one year
(10,890)
- 
Net current assets
1,833 
100 
Net assets
1,833 
100 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
1,733 
- 
Shareholders' funds
1,833 
100 
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 5 September 2024 and were signed on its behalf by
Gholamhossein LIAGHAT Director Company Registration No. 13875135
- 5 -
ALIA BIOTECH LTD Notes to the Accounts for the year ended 31 January 2024
1
Statutory information
ALIA BIOTECH LTD is a private company, limited by shares, registered in England and Wales, registration number 13875135. The registered office is 226 Upper Richmond Road West, London, London, SW14 8AH, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Trade creditors
450 
- 
Taxes and social security
406 
- 
Loans from directors
10,034 
- 
10,890 
- 
5
Average number of employees
During the year the average number of employees was 0 (2023: 0).
- 6 -